Testicular tumors. Mortality and recurrence after inadequate therapy;Hodentumoren todesfalle und rezidive nach inadaquater therapie

Urologe - Ausgabe A

Volumn 37, Issue 6, 1998, Pages 625-628

  Albers, P ^a   Dommer, K ^a   Muller S C ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Inadequate treatment; Recurrences; Testicular germ cell tumor

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; FOLLOW UP; GERM CELL TUMOR; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; ORCHIECTOMY; PARAAORTIC LYMPH NODE; RELAPSE; TESTIS TUMOR; TUMOR RECURRENCE; ADULT; AGED; CANCER STAGING; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEOPLASM; PATHOLOGY; SEMINOMA; SURVIVAL RATE;

ADULT; AGED; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; SEMINOMA; SURVIVAL RATE; TESTICULAR NEOPLASMS;

EID: 0031742363     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001200050225     Document Type: Article

References (11)

1. Baniel J, Foster RS, Gonin R, Messemer JE, Donohue JP, Einhorn LH (1995) Late relapse of testicular cancer. J Cin Oncol 13:1170-1176
2. Becker N, Wahrendorf J (1998) Krebsatlas der Bundesrepublik Deutschland/Atlas of cancer mortality in Germany, 3. Ausgabe. Springer, Berlin Heidelberg New York
3. Statistisches Bundesamt Wiesbaden (1992)
4. Cavalli F, Monfardini S, Pizzocaro G (1980) Report on the international workshop on staging and treatment of testicular cancer. EurJ Cancer 16:1367-1372
5. Gerl A, Clemm C, Hartenstein R (1994) Late relapse of nonseminomatous germ cell tumors (NSGCT) after cisplatin-based chemotherapy. Proc Am Soc Clin Oncol 13:229 (abstract 153)
6. International Germ Cell Cancer Collaborative Group (1997) International germ cell consensus classification: a prognostic factorbased staging system for metastatic germ cell cancers. J Clin Oncol 15:594-603
7. Howard GC, Clarke K, Elia MH, Hutcheon AW, Kaye SB, Windsor PM, Yosef HM, Sharp L (1995) A Scottish national mortality study assessing cause of death, quality of and variation in management of patients with testicular non-seminomatous germ cell tumours. BrJ Cancer 72:1307-1311
8. Read G, Stenning SP, Cullen MH, Parkinson MC, Horwich A, Kaye SB, Cook PA (1992) Medical Research Council prospective study of surveillance for stage I testicular teratoma. J Clin Oncol 10:1762-1768
9. Schölermann KH, Dettmann R, Hartmann M (1996) Die risikogesteuerte Hodentumornachsorge. Urologe [A] 35:326-330
10. Linger (1996) Epidemiologie von Hodentumoren in Niedersachsen.
11. Weißbach L, Bamberg M, Schmoll H-J (1997) Interdisziplinäre Konsensuskonferenz zur "Diagnostik und Therapie von Hodentumoren". Urologe [A] 36:362-368